Publications by authors named "Abdullah Igci"

Claim this Profile
F
Factors Predicting Additional Residual Nodal Disease With a Metastatic Sentinel Node Biopsy or Targeted Axillary Dissection After Neoadjuvant Chemotherapy.
Neslihan Cabıoğlu, Hasan Karanlık, Abdullah Iğci, Mahmut Müslümanoğlu, Okan Mustafa Gürsoy

J Breast Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omitting Axillary Dissection in Triple-Negative and HER2-Overexpressed Breast Cancers With Positive Sentinel Lymph Nodes During Upfront Surgery: SENATURK-OTHELLO Study.
Neslihan Cabıoğlu, Hasan Karanlık, Vahit Özmen, Mustafa Tükenmez, Abdullah İğci

Clin Breast Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing practice patterns in axillary management for patients with node-positive breast cancer towards increased use of sentinel lymph node biopsy-alone after neoadjuvant chemotherapy: results of a survey (MF17-01) among Turkish surgeons.
Neslihan Cabıoğlu, Damla Okan Ercan, İrem Karataş, Erhan Eröz, Safa Toprak

Langenbecks Arch Surg· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De-Escalation of Nodal Surgery in Clinically Node-Positive Breast Cancer.
Neslihan Cabioglu, Havva Belma Koçer, Hasan Karanlik, Mehmet Ali Gülçelik, Abdullah Igci

JAMA Surg· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02/18-03.
Neslihan Cabioglu, Hasan Karanlik, Abdullah Igci, Mahmut Muslumanoglu, Mehmet Ali Gulcelik

Ann Surg Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Author Reflections: Nodal Recurrence Is Rare in Patients with cN+/ycN0 Breast Cancer after Neoadjuvant Chemotherapy Regardless of the Extent of Axillary Surgery or Nodal Pathology in the NEOSENTITURK-Trials MF18-02/18-03 Provided Regional Nodal Irradiation Is Administered.
Neslihan Cabioglu, Hasan Karanlik, Abdullah Igci, M Muslumanoglu, Mehmet Ali Gulcelik

Ann Surg Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined analysis of the MF18-02/MF18-03 NEOSENTITURK studies: ypN-positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuvant chemotherapy as long as radiotherapy is provided.
Mahmut Muslumanoglu, Neslihan Cabioglu, Abdullah Igci, Hasan Karanlık, Havva Belma Kocer

Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy.
Mahmut Muslumanoglu, Baran Mollavelioglu, Neslihan Cabioglu, Selman Emiroglu, Mustafa Tukenmez, Abdullah Igci

World J Surg Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Emerging Chemokine Receptors: CCR5 or CXCR5 on Tumor Is Associated with Poor Response to Chemotherapy and Poor Prognosis in Locally Advanced Triple-Negative Breast Cancer.
Neslihan Cabioglu, Semen Onder, Hüseyin Karatay, Aysel Bayram, Gizem Oner, Abdullah Igci

Cancers (Basel)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes and predictors of recurrence in node-negative early stage breast cancer patients.
Izzet Dogan, Esra Aydin, Nijat Khanmammadov, Nail Paksoy, Ferhat Ferhatoğlu, Abdullah Igci

J Cancer Res Clin Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ozone therapy as a novel complementary therapeutic approach in refractory idiopathic granulomatous mastitis.
Neslihan Cabioglu, Didem Can Trabulus, Selman Emiroglu, Enver Ozkurt, Nesli Yalcin, Abdullah Igci

Front Med (Lausanne)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancer.
Neslihan Cabioglu, Aysel Bayram, Selman Emiroglu, Semen Onder, Huseyin Karatay, Abdullah Igci

Front Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Benign Breast Diseases With or Without Atypical Epithelial Hyperplasia Accompanying Radial Scars.
Zeliha Turkyilmaz, Elif Sarisik, Enver Ozkurt, Mustafa Tukenmez, Selman Emiroglu, Abdullah Igci

Eur J Breast Health· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Hypofractionated Radiotherapy Schedule with a Simultaneous Integrated Boost for Breast Cancer: Outcomes including Late Toxicity and Health Quality.
Zuleyha Akgun, Aydin Cakir, Esra Sağlam, Sertac Demirel, Abdullah Igci

Medicina (Kaunas)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy.
Gizem Oner, Semen Önder, Hüseyin Karatay, Naziye Ak, Mustafa Tükenmez

World J Surg Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with or Germline Mutation?
Selman Emiroglu, Enver Özkurt, Neslihan Cabıoglu, Abdullah Igci, Pinar Saip

Breast Cancer (Dove Med Press)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ozone therapy restores immune dysfunction in refractory idiopathic granulomatous mastitis as a novel potential therapeutic approach.
Neslihan Cabioglu, Esin Cetin Aktas, Selman Emiroglu, Mustafa Tukenmez, Enver Ozkurt, Abdullah Igci

Cell Biol Int· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metaplastic Breast Cancer: Mesenchymal Subtype Has Worse Survival Outcomes.
Enver Özkurt, Selman Emiroğlu, Neslihan Cabioğlu, Hasan Karanlık, Semen Önder

Breast Care (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer.
Baran Mollavelioglu, Esin Cetin Aktas, Neslihan Cabioglu, Aykhan Abbasov, Semen Onder, Abdullah Igci

World J Surg Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abbreviated and Standard Breast MRI in Neoadjuvant Chemotherapy Response Evaluation: A Comparative Study.
Inci Kizildag Yirgin, Gulgun Engin, Şeyma Yildiz, Esra Cureoglu Aydin, Hasan Karanlik, Abdullah Igci

Curr Med Imaging· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Surgery with Systemic Therapy in Patients with de Novo Stage IV Breast Cancer: 10-year Follow-up; Protocol MF07-01 Randomized Clinical Trial.
Atilla Soran, Vahit Ozmen, Serdar Ozbas, Hasan Karanlik, Mahmut Muslumanoglu, Abdullah Igci

J Am Coll Surg· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Expression of Novel Immune Checkpoint Receptors on Tumor Infiltrating Lymphocytes in Patients with Locally Advanced Breast Cancer after Neoadjuvant Chemotherapy.
Aykhan Abbasov, Esin Aktas Cetin, Neslihan Cabioglu, Baran Mollavelioglu, Semen Onder, Abdullah Igci

Neoplasma· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy.
Gizem Oner, Semen Önder, Hüseyin Karatay, Naziye Ak, Mustafa Tükenmez

World J Surg Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of loco-regional treatment in long-term quality of life in de novo stage IV breast cancer patients: protocol MF07-01Q.
Atilla Soran, Aykut Soyder, Serdar Ozbas, Vahit Ozmen, Hasan Karanlik, Abdullah Igci

Support Care Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer.
Neslihan Cabioglu, Semen Onder, Gizem Oner, Hüseyin Karatay, Mustafa Tukenmez

BMC Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis